Health In Tech
HIT · NASDAQ
About HIT
- Employees
- 89
- Headquarters
- Stuart, Florida
- Listed
- Dec 23, 2024
- Sector
- Financials
- Industry
- Insurance
- Website
- healthintech.com
HIT key statistics
- Market cap
- 36.84M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 413.30K
- Volume
- 125.30K
- Open price
- $0.6287
- High today
- $0.6502
- Low today
- $0.5552
- 52 Week high
- $3.35
- 52 Week low
- $0.6141
Health In Tech (HIT) at a glance
Health In Tech (HIT) last traded at $0.5642, with a market cap of 36.84M and a price-to-earnings ratio of 0.00.
Today the stock has traded between $0.5552 and $0.6502. The current price is 1.6% above the day's low and 13.2% below its high.
Volume so far is 125.30K shares, below the average of 413.30K shares a day.
Over the past year Health In Tech has ranged from $0.6141 to $3.35, and now sits -2% of the way up that range.
Health In Tech met or beat analyst EPS estimates in 2 of the last 6 quarters. In Q2 FY26 it reported -$0.03 per share against an estimate of -$0.0236.
The average analyst price target is $3.77, 568.9% above the current price, from 2 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy100.0%
- Hold0.0%
- Sell0.0%
- Low
- $3.03
- Now
- $0.5642
- High
- $4.30
HIT earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 2 of the last 6 quarters, by 55.4% on average.
- Q1 FY25: reported $0.01 per share against an estimate of $0.0202
- Q2 FY25: reported $0.01 per share against an estimate of $0.0101
- Q3 FY25: reported $0.01 per share against an estimate of $0.0101
- Q4 FY25: reported $0.001 per share against an estimate of -$0.0101
- Q1 FY26: reported -$0.03 per share against an estimate of -$0.0303
- Q2 FY26: reported -$0.03 per share against an estimate of -$0.0236
HIT news
- Press releasePRNewswire
- Press releasePRNewswire
Health In Tech to Host Annual Meeting of Stockholders
- Press releasePRNewswire
Health In Tech Launches HitRix, a Broker-First Environment for Self-Funded Stop-Loss Placement
- Press releasePRNewswire
Health In Tech to Attend the 17th Annual Craig-Hallum Alpha Select Conference
- Press releasePRNewswire
Health In Tech Launches HitRix to Modernize the Nearly $1 Trillion U.S. Self-Funded Health Insurance Market and Announces Updated 2026 Full-Year Revenue Guidance
- Press releasePRNewswire
Health In Tech Named to Newsweek's America's Greatest Mid-Market Companies 2026
Health In Tech Q2 2026 Earnings Call: Complete Transcript
- Press releasePRNewswire
Health In Tech Reports Second Quarter 2026 Financial Results
Similar companies
Companies in the same industry as Health In Tech
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.